PKM and lung carcinoma: PKM2 stabilizes VDAC3 by inhibiting its ubiquitination and degradation of VDAC3, thereby increasing mitochondrial permeability and ATP production, thus promoting cell survival and tumorigenesis.[44] The Regulation of SIRT5 on PKM2 has also been observed in lung cancer cells.